Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 7 Apr 23 424B3 Prospectus supplement
- 6 Apr 23 EFFECT Notice of effectiveness
- 4 Apr 23 POS AM Prospectus update (post-effective amendment)
- 15 Feb 23 424B3 Prospectus supplement
- 7 Feb 23 424B3 Prospectus supplement
- 6 Jan 23 424B3 Prospectus supplement
- 28 Dec 22 EFFECT Notice of effectiveness
- 27 Dec 22 424B3 Prospectus supplement
-
19 Dec 22 S-1 IPO registration
PXMD similar filings
Filing view
External links
EXHIBIT 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the inclusion in this Registration Statement of PaxMedica, Inc. on Form S-1 of our report dated June 10, 2022, which includes an explanatory paragraph as to Company's ability to continue as a going concern with respect to our audits of the financial statements of PaxMedica, Inc. as of December 31, 2021 and 2020 and for the years ended December 31, 2021 and 2020, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum LLP
Marcum LLP
New York, NY
December 16, 2022